NCT00474851View on ClinicalTrials.gov

The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2015

Conditions
Endometriosis
Interventions
DRUG

Norethindrone acetate + estrogens

Norethindrone acetate 5 mg by mouth daily + Conjugated equine estrogens 0.625 mg by mouth daily

DRUG

norethindrone acetate + placebo

norethindrone acetate 5 mg by mouth daily + Placebo capsule 1 pill by mouth daily

Trial Locations (1)

02115

Children's Hospital Boston, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Boston Children's Hospital

OTHER

NCT00474851 - The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial | Biotech Hunter | Biotech Hunter